{
    "nctId": "NCT04637308",
    "briefTitle": "Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy",
    "officialTitle": "A Randomized, Phase II Study of Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Fluid Retention",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 216,
    "primaryOutcomeMeasure": "Total incidence of fluid retention",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Signed informed consent\n* Age \u226518 years\n* Diagnosed with breast cancer\n* ECOG 0-2\n* Received chemotherapy with docetaxel\n\nExclusion Criteria:\n\n* Existed peripheral edema, ascites and pleural or pericardial effusion\n* Serum creatinine exceeds 1.5 times of the upper normal limit\n* Total serum bilirubin exceeds 1.25 times of the upper normal limit, or ASAT exceeds 2 times of the upper normal limit",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}